India to United Arab Emirates: Carfilzomib Export Trade Route

The India to United Arab Emirates Carfilzomib corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $33.5K USD. The route is dominated by SARTAJ PHARMA PRIVATE LIMITED, which alone accounts for roughly 57% of all export value, reflecting the consolidated nature of India's carfilzomib manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $2.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with carfilzomib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 33.8%, placing it at rank #2 among India's top carfilzomib export destinations globally.

On the import side, key buyers of Indian carfilzomib in United Arab Emirates include RAFTAR MARIME FZE, SMARK FZE, TO THE IMPORT MANAGER and 5 others. RAFTAR MARIME FZE is the single largest importer with 4 shipments valued at $19.2K USD.

India's carfilzomib exports to United Arab Emirates are driven primarily by a handful of large-scale manufacturers. SARTAJ PHARMA PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in United Arab Emirates benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SARTAJ PHARMA PRIVATE LIMITED, AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, KINGS GLOBAL BIOTECH LIMITED — together account for 81% of total trade value on this route. The average shipment value of $2.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma product- carfilnat 60 mg inj eachvial contains carfilzomib 60 mg batch no. jd40823005 manufacturing . date. 01-23 exp date and carfilzomib 60mg/vial inj.b no:-jd40823005,jd40823006,jd40823007md-07/23,ed-12/24,jd40823007,md-10/23.ed-03/25, suggesting that buyers in United Arab Emirates tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, RAFTAR MARIME FZE is the largest importer with 4 shipments worth $19.2K USD — representing 57% of all carfilzomib imports from India on this route. A total of 8 buyers are active on this corridor.